# Pfizer Inc. (PFE) — Q2-2016 Earnings Results

**Report date:** 2016-08-02 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q2-2016

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Down 2.47%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.64 | N/A | +2.56% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Overall, management conveyed a cautious outlook amid market uncertainties. They stressed the need for continued focus on innovation.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized the importance of strategic investments moving forward.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's earnings report showed a slight beat on EPS, which indicates some positive performance despite broader challenges. However, the stock fell by 2.47%, likely reflecting investor concerns about the lack of revenue data and the overall market environment. The cautious tone from management suggests that investors should remain vigilant about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q2-2016_